Oral glucose tolerance Test (OGTT): A plasma glucose of ≥200 mg/dL
(or 11.1 mmol/L) 2 hours after ingesting 75 g oral glucose.
Random plasma glucose test: A plasma of ≥200 mg/dL or 11.1 mmol/L.
Glycosylated hemoglobin A1C: ≥6.0%.Treatment
Type 1:- Regular monitoring of blood glucose.
- Administer insulin to maintain normal blood glucose levels (see
Table 9-1). - Maintain a diabetic diet.
- Administer:
Rapid acting:
Aspart
Lispro
Glulisine
Short acting:
Regular insulin
Intermediate:
Human insulin
NPH
Human insulin
Zinc
Lente
Long acting:
Human insulin
Zinc
Ultralente
Glargine
Lantus
Inhaled insulin
Exubera: A short-acting insulin for before-meal control
3(^186) Pediatric Nursing Demystified
Insulin Drug Synonym Appearance Onset Peak Duration Compatibility
Rapid acting Regular Clear 0.5–1 h 2–4 h 6–8 h All insulin
except lente
Intermediate NPH Cloudy 1–1.5 h 8–12 h 18–24 h Regular
acting insulin
Long acting Ultralente Cloudy 4–6 h 16–20 h 30–36 h Regular
TABLE 9–1•Insulin Guide